Last Updated: November 13, 2026

Acella Company Profile

« Back to Dashboard


What is the competitive landscape for ACELLA

ACELLA has thirteen approved drugs.



Summary for Acella
US Patents:0
Tradenames:12
Ingredients:12
NDAs:13
Patent Litigation for Acella: See patent lawsuits for Acella

Drugs and US Patents for Acella

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Acella BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE brompheniramine maleate; dextromethorphan hydrobromide; pseudoephedrine hydrochloride SYRUP;ORAL 203375-001 Sep 20, 2016 AA RX No No ⤷  Start Trial ⤷  Start Trial
Acella DOXYCYCLINE HYCLATE doxycycline hyclate TABLET;ORAL 210664-001 Mar 16, 2020 AB RX No No ⤷  Start Trial ⤷  Start Trial
Acella CICLOPIROX ciclopirox SOLUTION;TOPICAL 078172-001 Sep 18, 2007 AT RX No No ⤷  Start Trial ⤷  Start Trial
Acella HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE chlorpheniramine maleate; hydrocodone bitartrate SOLUTION;ORAL 206891-001 Jun 9, 2017 DISCN No No ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.